Eli Lilly’s Obesity Pill & Tim Cook at the White House 8/7/25 - podcast episode cover

Eli Lilly’s Obesity Pill & Tim Cook at the White House 8/7/25

Aug 07, 202539 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

President Trump has announced he will impose a 100% tariff on chips and semiconductors imports, although he’s suggested exemptions for companies manufacturing in the U.S. One company that may qualify for that exemption: Apple. During CEO Tim Cook’s meeting with the President on Wednesday, Cook committed an additional $100 billion to onshore manufacturing. Author Walter Isaacson discusses Cook’s commitment in the context of Steve Jobs’ original plans to manufacture Apple products in America. President Trump also has another tech CEO in his sights, calling for the resignation of Intel’s Lip-Bu Tan on social media. CNBC’s Angelica Peebles reveals the latest obesity pill trial results from Eli Lilly. Orfoglipron’s results were similar to Wegovy, and investors are disappointed by the data and the rate of discontinuation among trial participants. Plus, Lyft CEO David Risher explains his company’s earnings report, strong on paper but disappointing to some investors. 

 

Megan Cassella - 5:35

Angelica Peebles - 13:03

Walter Isaacson - 20:47

David Risher - 35:21

 

In this episode:

Megan Cassella, @mmcassella

Angelica Peebles, @angelicapeebles

Joe Kernen, @JoeSquawk 

Andrew Ross Sorkin, @andrewrsorkin

Melissa Lee, @MelissaLeeCNBC

Katie Kramer, @Kramer_Katie


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

For the best experience, listen in Metacast app for iOS or Android